|
Neurology Devices
A novel electric stimulation technology for treatment of severe
obstructive sleep apnea. The product provides selective nerve
stimulation which maintains airway patency.
Medical devices that restore cognitive function in patients affected
by trauma and neurodegenerative disorders. Indications include
stroke, Alzheimer’s disease, vascular insufficiency, and
normal pressure hydrocephalus.
Orthopedics & Tissue
Engineering
Breakthrough hyaluronan-based hydrogels with orthopedic and tissue
engineering applications. The unique patent-pending chemistry utilizes
naturally occurring substrates and includes clinical applications
for cartilage repair/replacement, joint lubrication, and repair
of intervertebral discs.
Bioneer Surgical is developing a new polymeric biomaterial for
orthopedic applications. This versatile osteoconductive biomaterial
can be formulated as a bone cement, bone void filler, bone graft
substitute, or bone-to-soft tissue adhesive, and can act as a carrier
for orthobiologics.
Specialty Pharmaceuticals
A company developing the next generation of unique targeted chemotherapeutic
drugs, and radio- and chemosensitizers for the treatment of cancer.
The lead drug candidate is a small molecule therapeutic about to
begin its Phase II clinical study in multiple myleoma patients
refractory to other treatments. Other candidates include
agents licensed from Dana Farber Cancer Institute, The University
of Chicago and The Cleveland Clinic. The company is being led by
a co-founder of Centocor.
A company that will offer a broad line of acute need therapeutics,
products for chronic conditions, and skin health maintenance products
which will provide optimized systems of care. Innovative new drugs
and advanced formulation expertise will establish the Company as
a leader in skin care, repair, and protection. Access to
innovative and high quality products will be extended through the
Company’s relationship to strategic partners Spirig Pharma
Ltd. and Ricerca Biosciences, LLC.
Health Care Services
A company that is the leader in quality and service for the on-site
health care industry. The company’s program enables employers
to provide self-insured health care to employees ranging from primary
and urgent care to preventative health and wellness programs while
also reducing costs and increasing employee productivity.
A company that delivers an affordable, reliable Electronic Medical
Records (EMR) solution to small and midsized physician practices. Its
product is the first EMR solution to combine software, local training
and support, and remote hosting into a subscription-based service.
The product is the highest-rated EMR system in the marketplace
for small practices, according to the leading industry consultant,
AC Group.
Cell Therapies
A cord-blood derived stem cell therapy that generates new blood vessels in ischemic tissues. The therapy is currently in a Phase I clinical safety study for coronary applications.
Click
here to see a full list of BioEnterprise companies.
|
